Kathleen Goin, Chief Operating Officer at PALVELLA THERAPEUTICS, INC. (PVLA), sold 8,604 shares at $117.56 ($1.0M) on 2026-03-18, disclosed to the SEC on 2026-03-20.
Scheduled sale ($1.0M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.56 | 2,268 | $267K | 26.3% |
| 2 | $117.56 | 2,268 | $267K | 26.3% |
| 3 | $118.37 | 1,730 | $205K | 20.2% |
| 4 | $118.37 | 1,730 | $205K | 20.2% |
| 5 | $119.08 | 304 | $36K | 3.6% |
| 6 | $119.08 | 304 |
| $36K |
| 3.6% |
| Total | $117.99 avg | 8,604 | $1.0M | 100% |
| Filing → |
| PVLA | SELL | 2026-07-17 | $642K | — | Filing → |
| PVLA | SELL | 2026-06-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-05-22 | $476K | — | Filing → |